Abstract
Purpose
To improve the test–retest reproducibility of coronary plaque 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) uptake measurements.
Methods
We recruited 20 patients with coronary artery disease who underwent repeated hybrid PET/CT angiography (CTA) imaging within 3 weeks. All patients had 30-min PET acquisition and CTA during a single imaging session. Five PET image-sets with progressive motion correction were reconstructed: (i) a static dataset (no-MC), (ii) end-diastolic PET (standard), (iii) cardiac motion corrected (MC), (iv) combined cardiac and gross patient motion corrected (2 × MC) and, (v) cardiorespiratory and gross patient motion corrected (3 × MC). In addition to motion correction, all datasets were corrected for variations in the background activities which are introduced by variations in the injection-to-scan delays (background blood pool clearance correction, BC). Test–retest reproducibility of PET target-to-background ratio (TBR) was assessed by Bland–Altman analysis and coefficient of reproducibility.
Results
A total of 47 unique coronary lesions were identified on CTA. Motion correction in combination with BC improved the PET TBR test–retest reproducibility for all lesions (coefficient of reproducibility: standard = 0.437, no-MC = 0.345 (27% improvement), standard + BC = 0.365 (20% improvement), no-MC + BC = 0.341 (27% improvement), MC + BC = 0.288 (52% improvement), 2 × MC + BC = 0.278 (57% improvement) and 3 × C + BC = 0.254 (72% improvement), all p < 0.001). Importantly, in a sub-analysis of 18F-NaF-avid lesions with gross patient motion > 10 mm following corrections, reproducibility was improved by 133% (coefficient of reproducibility: standard = 0.745, 3 × MC = 0.320).
Conclusion
Joint corrections for cardiac, respiratory, and gross patient motion in combination with background blood pool corrections markedly improve test–retest reproducibility of coronary 18F-NaF PET.
Similar content being viewed by others
Abbreviations
- 18F-NaF:
-
18F-sodium fluoride
- PET:
-
positron emission tomography
- CTA:
-
coronary computed tomography angiography
- MC:
-
cardiac motion corrected
- 2 × MC:
-
cardiac and gross patient motion corrected
- 3 × MC:
-
cardiac, respiratory, and gross patient motion corrected
- BC:
-
background blood pool clearance correction
- TBR:
-
tTarget to background ratio
- SUV:
-
Standardized uptake value
- VOI:
-
Volume of Interest
References
Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705–13. Available from: https://doi.org/10.1016/S0140-6736(13)61754-7. Open Access article distributed under the terms of CC BY.
Cocker MS, Spence JD, Hammond R, Wells G, DeKemp RA, Lum C, et al. [18F]-NaF PET/CT identifies active calcification in carotid plaque. JACC Cardiovasc Imaging. 2017;10:486–8.
Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–11.
Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV, et al. Detection of atherosclerotic inflammation by68Ga-DOTATATE PET compared to [18F]FDG PET imaging. J Am Coll Cardiol. 2017;69:1774–91.
Dawood M, Büther F, Stegger L, Jiang X, Schober O, Schäfers M, et al. Optimal number of respiratory gates in positron emission tomography: a cardiac patient study. Med Phys. 2009;36:1775–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19544796.
Rubeaux M, Joshi NV, Dweck MR, Fletcher A, Motwani M, Thomson LE, et al. Motion correction of 18F-NaF PET for imaging coronary atherosclerotic plaques. J Nucl Med. 2016;57:54–9. Available from: http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.115.162990.
Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: implications for coronary 18 F-NaF PET imaging. J Nucl Med. 2019;60(6):830–6. https://doi.org/10.2967/jnumed.118.217877.
Massera D, Doris MK, Cadet S, Kwiecinski J, Pawade TA, Peeters FECM, et al. Analytical quantification of aortic valve 18F-sodium fluoride PET uptake. J Nucl Cardiol. 2018. Available from: http://link.springer.com/10.1007/s12350-018-01542-6. Epub ahead of print.
Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A, et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol. 2018. Available from. https://doi.org/10.1007/s12350-018-1317-5. Epub ahead of print.
Kwiecinski J, Berman DS, Lee S-E, Dey D, Cadet S, Lassen ML, et al. Three-hour delayed imaging improves assessment of coronary 18 F-sodium fluoride PET. J Nucl Med. 2019;60(4):530–5. https://doi.org/10.2967/jnumed.118.217885.
Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, et al. Optimizing18F-FDG PET/CT imaging of vessel wall inflammation: the impact of18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging. 2014;41:369–83.
National Library of Medicine (U.S.). Dual Antiplatelet Therapy to Reduce Myocardial Injury. 2014. Accessed 4th December 2018 [internet]. Available from: https://clinicaltrials.gov/show/NCT02110303.
Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GBJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342–58.
Lassen ML, Kwiecinski J, Slomka PJ. Gating approaches in cardiac PET imaging. PET Clin. 2019;14:271–9.
Daube-Witherspoon ME, Muehllehner G. Treatment of axial data in three-dimensional PET. J Nucl Med.1987;28:1717–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3499493.
Kwiecinski J, Adamson PD, Lassen ML, Doris MK, Moss AJ, Cadet S, et al. Feasibility of coronary 18F-sodium fluoride PET assessment with the utilization of previously acquired CT angiography. Circ Cardiovasc Imaging. 2018;11:e008325..
Pawade TA, Cartlidge TRG, Jenkins WSA, Adamson PD, Robson P, Lucatelli C, et al. Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis. Circ Cardiovasc Imaging. 2016;9:1–11.
Dweck MR, Chow MWL, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–48
Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, et al. Predictive value of 18 F-sodium fluoride positron emission tomography in detecting high-risk coronary artery disease in combination with computed tomography. J Am Heart Assoc. 2018;7(20):e010224. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.010224.
Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med. 2015;56:503–4.
Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.
Laffon E, Lamare F, De Clermont H, Burger IA, Marthan R. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak. Eur Radiol. 2014;24:1964–70.
National Library of Medicine (U.S.). Study prediction of recurrent events with 18F-Fluoride. https://ClinicalTrials.gov/show/NCT02278211. Accessed 4 Dec 2018.
Doris MK, Rubeaux M, Pawade T, Otaki Y, Xie Y, Li D, et al. Motion-corrected imaging of the aortic valve with 18 F-NaF PET/CT and PET/MRI: a feasibility study. J Nucl Med. 2017;58:1811–4. Available from: http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.117.194597.
Feng T, Wang J, Fung G, Tsui B. Non-rigid dual respiratory and cardiac motion correction methods after , during , and before image reconstruction for 4D cardiac PET. Phys Med Biol. 2015;61:151–68.
Funding
This research was supported in part by grant R01HL135557 from the National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, the study was supported by Siemens Medical Systems. The study was also supported by a grant (“Cardiac Imaging Research Initiative”) from the Miriam & Sheldon G. Adelson Medical Research Foundation. DEN is supported by the British Heart Foundation (CH/09/002, RM/13/2/30158, RE/13/3/30183) and is the recipient of a Wellcome Trust Senior Investigator Award (WT103782AIA). MRD is supported by the Sir Jules Thorn Biomedical Research Award (JTA/15) and the British Heart Foundation (FS/14/78/31020). None of the other authors have any conflict of interest relevant to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were approved by the local institutional review board, the Scottish Research Ethics Committee (REC reference: 14/SS/0089 and 15/SS/0203), and the United Kingdom (UK) Administration of Radiation Substances Advisory Committee. The study was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent prior to any study procedures.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Cardiology
Rights and permissions
About this article
Cite this article
Lassen, M.L., Kwiecinski, J., Dey, D. et al. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET. Eur J Nucl Med Mol Imaging 46, 2610–2620 (2019). https://doi.org/10.1007/s00259-019-04437-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04437-x